We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Appeals Court Deals Teva Another Blow, Invalidating Several Copaxone Patents
Appeals Court Deals Teva Another Blow, Invalidating Several Copaxone Patents
July 30, 2013
The U.S. Court of Appeals for the Federal Circuit July 26 reversed a district court’s finding related to Teva’s ‘808 patent for Copaxone, invalidating it and nixing any hopes the drugmaker had of maintaining exclusivity on its blockbuster MS drug until 2015.